Picard Medical Faces Class Action Lawsuit

Bragar Eagel & Squire Reminds Investors of Lawsuit Over Stock Promotion Scheme

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Bragar Eagel & Squire, P.C., a national stockholder rights law firm, has filed a class action lawsuit against Picard Medical, Inc. (NYSE:PMI) on behalf of investors who purchased or acquired Picard securities between September 2, 2025, and October 31, 2025. The lawsuit alleges that Picard failed to disclose a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, as well as insider trading through offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign.

Why it matters

The lawsuit against Picard Medical highlights the growing problem of stock manipulation schemes, which can lead to significant losses for investors. This case raises concerns about the need for greater transparency and oversight in the financial markets to protect individual investors from such fraudulent activities.

The details

According to the complaint, Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price. On October 24, 2025, Picard's stock price abruptly crashed 70%, to $3.99 per share, and has continued to decline to approximately $2.00 per share.

  • The class period is from September 2, 2025, to October 31, 2025.
  • Investors have until April 3, 2026, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The players

Bragar Eagel & Squire, P.C.

A nationally recognized stockholder rights law firm with offices in New York, South Carolina, and California.

Brandon Walker

Litigation Partner at Bragar Eagel & Squire, P.C.

Melissa Fortunato

Litigation Partner at Bragar Eagel & Squire, P.C.

Picard Medical, Inc.

A publicly traded medical device company that is the subject of the class action lawsuit.

Got photos? Submit your photos here. ›

What they’re saying

“If you purchased or otherwise acquired Picard shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.”

— Brandon Walker, Litigation Partner, Bragar Eagel & Squire, P.C. (Bragar Eagel & Squire, P.C.)

What’s next

Investors have until April 3, 2026, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The takeaway

This case highlights the need for greater transparency and oversight in the financial markets to protect individual investors from fraudulent stock promotion schemes and manipulative trading practices. Investors should be cautious of any suspicious activity or unsubstantiated claims about a company's performance and seek professional advice before making investment decisions.